Postural orthostatic tachycardia syndrome following SARS-CoV-2 infection
and COVID-19 vaccination: A comparative review
Abstract
The coronavirus disease 2019 (COVID-19) has shown unexpected viral
infection traits. Initially thought to affect respiratory health
primarily, it also involves the gastrointestinal system. However, many
complications during the pandemic were caused by the virus, including
neurological, cardiovascular, dermatological, and metabolic issues.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has also
been linked to cardiac complications, such as myocardial infarction, in
individuals without cardiovascular risk factors. SARS-CoV-2 vaccines
exacerbated the situation with possible adverse events (AEs). Vaccine
side effects, like thromboembolic events, can be life-threatening or
simply bothersome. Postural orthostatic tachycardia syndrome (POTS) is a
nonlethal cardiac complication seen with COVID-19 and its vaccines. In
this review, we summarized the POTS-COVID-19 relationship
comprehensively.